Most patients unaware if their insurance covers telehealth

While more telehealth initiatives are popping up across the healthcare space, consumers aren’t as clear on whether their insurance plans actually cover virtual care services.

Almost half–46 percent– of 781 Medicare Advantage (MA) members surveyed by HealthMine said they weren’t sure if their plan offered or recommended online and phone-based services. Just 17 percent noted the services were offered, while 37 percent said telehealth is not offered.

HealthMine, a clinical technology company within a value-based insurance design plan, conducted its HealthMine Medicare Survey of consumers 65 and older with a chronic condition who were enrolled in a MA and/or supplemental plan. The awareness of MA members was slightly higher than in 2017, when 57 percent said they were unsure about telehealth offerigns.

The results come as several new telehealth initiatives have been thrust into the spotlight. CMS recently announced in its 2019 Physician Fee Schedule that it would reimburse virtual care. On the private sector side, CVS also announced a new telehealth service, MinuteClinic Video Visits, for $59 per visit.

While few consumers knew if their plan covered such services, 77 percent of respondents used a smart device and were computer literate.

MA plans are currently awaiting telehealth reimbursement decisions for 2020, as expansions for coverage were included in the budget deal signed by President Donald Trump in early 2018.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.